These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 25965589)

  • 1. Ticagrelor-induced acute generalized exanthematous pustulosis.
    Maybrook RJ; Fischer R; Deibert B; Gillihan R; Laarman R; Fraga G; Aires D; Gollub S
    Int J Cardiol; 2015 Jul; 191():11-2. PubMed ID: 25965589
    [No Abstract]   [Full Text] [Related]  

  • 2. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis.
    Steg PG; James S; Harrington RA; Ardissino D; Becker RC; Cannon CP; Emanuelsson H; Finkelstein A; Husted S; Katus H; Kilhamn J; Olofsson S; Storey RF; Weaver WD; Wallentin L;
    Circulation; 2010 Nov; 122(21):2131-41. PubMed ID: 21060072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary antiplatelet therapy in acute coronary syndromes: are there differences in outcomes and discontinuation between clopidogrel and ticagrelor?
    Harding SA; Holley A; Wilkins B; Fairley S; Simmonds M; Larsen PD
    Intern Med J; 2017 Nov; 47(11):1298-1305. PubMed ID: 28857445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).
    Alexopoulos D; Goudevenos JA; Xanthopoulou I; Deftereos S; Sitafidis G; Kanakakis I; Hamilos M; Parissis H; Ntalas IV; Angelidis C; Petousis S; Vavuranakis M; Hahalis G; Stefanadis C;
    Int J Cardiol; 2013 Oct; 168(6):5329-35. PubMed ID: 23978364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome: A pharmacodynamic analysis.
    Chen Y; Dong W; Wan Z; Li Z; Cong H; Hong T; Yin T
    Int J Cardiol; 2015 Dec; 201():545-6. PubMed ID: 26325437
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis induced by clopidogrel.
    Ulman CA; Palmer DG; Trevino JJ; Olsen TG; Krishnamurthy S; Gandhi RK
    Int J Dermatol; 2014 Oct; 53(10):e461-2. PubMed ID: 24739100
    [No Abstract]   [Full Text] [Related]  

  • 7. Ticagrelor as an alternative in clopidogrel-associated neutropenia.
    Shah R; Keough LA; Belalcazar-Portacio A; Ramanathan KB
    Platelets; 2015; 26(1):80-2. PubMed ID: 24433137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching patients from clopidogrel to novel P2Y12 receptor inhibitors in acute coronary syndrome: comparative effects of prasugrel and ticagrelor on platelet reactivity.
    Lhermusier T; Voisin S; Murat G; Mejean S; Garcia C; Bataille V; Lipinski MJ; Carrié D; Sié P
    Int J Cardiol; 2014 Jul; 174(3):874-6. PubMed ID: 24820749
    [No Abstract]   [Full Text] [Related]  

  • 9. Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: A prospective randomized study.
    Bonello L; Frere C; Cointe S; Laine M; Mancini J; Thuny F; Kerbaul F; Lemesle G; Paganelli F; Guieu R; Arnaud L; Dignat-George F; Sabatier F
    Int J Cardiol; 2015; 187():502-7. PubMed ID: 25846661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antiplatelet agents in the treatment of acute coronary syndromes.
    Sabouret P; Taiel-Sartral M
    Arch Cardiovasc Dis; 2014 Mar; 107(3):178-87. PubMed ID: 24630752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor: oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes.
    Cheng JW
    Clin Ther; 2012 Jun; 34(6):1209-20. PubMed ID: 22521881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor: a novel reversible oral antiplatelet agent.
    Nawarskas JJ; Clark SM
    Cardiol Rev; 2011; 19(2):95-100. PubMed ID: 21285670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ticagrelor approved for acute coronary syndrome.
    Traynor K
    Am J Health Syst Pharm; 2011 Sep; 68(17):1568. PubMed ID: 21856798
    [No Abstract]   [Full Text] [Related]  

  • 14. Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?
    Kowalczyk M; Banach M; Mikhailidis DP; Hannam S; Rysz J
    Med Sci Monit; 2009 Dec; 15(12):MS24-30. PubMed ID: 19946242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Evidence on Platelet P2Y12 Receptor Inhibitors: Is There Still a Role for Clopidogrel in 2015?
    Qutub MA; Chong AY; So DY
    Can J Cardiol; 2015 Dec; 31(12):1481-4. PubMed ID: 26243350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ticagrelor: the silence of the platelets.
    Laine M; Paganelli F; Bonello L
    Expert Opin Pharmacother; 2013 Feb; 14(2):151-3. PubMed ID: 23294190
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes.
    Storey RF; Becker RC; Harrington RA; Husted S; James SK; Cools F; Steg PG; Khurmi NS; Emanuelsson H; Cooper A; Cairns R; Cannon CP; Wallentin L
    Eur Heart J; 2011 Dec; 32(23):2945-53. PubMed ID: 21804104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyspnea in patients treated with P2Y
    Alexopoulos D; Xanthopoulou I; Perperis A; Goudevenos J; Hamilos M; Sitafidis G; Kanakakis I; Vavouranakis M; Giannopoulos G; Barampoutis N; Deftereos S; Lekakis J
    Platelets; 2017 Nov; 28(7):691-697. PubMed ID: 28150522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome.
    Caiazzo G; De Rosa S; Torella D; Spaccarotella C; Mongiardo A; Giampà S; Micieli M; Palella E; Gulletta E; Indolfi C
    Circ Cardiovasc Interv; 2014 Feb; 7(1):104-12. PubMed ID: 24449597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor for acute coronary syndromes.
    Bansilal S; Bonaca MP; Sabatine MS
    Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1473-84. PubMed ID: 24147518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.